IL127366A0 - Insulin preparations containing NaCl - Google Patents

Insulin preparations containing NaCl

Info

Publication number: IL127366A0
Authority: IL; Israel
Prior art keywords: insulin preparations; preparations containing; containing nacl; insulin; nacl
Prior art date: 1996-06-20

Application number

IL12736697A

Other languages

English (en)

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-20

Filing date

1997-06-19

Publication date

1999-10-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8096378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127366(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-06-19 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1999-10-28 Publication of IL127366A0 publication Critical patent/IL127366A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL12736697A 1996-06-20 1997-06-19 Insulin preparations containing NaCl IL127366A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK68596		1996-06-20
PCT/DK1997/000268 WO1997048414A1 (en)	1996-06-20	1997-06-19	INSULIN PREPARATIONS CONTAINING NaCl

Publications (1)

Publication Number	Publication Date
IL127366A0 true IL127366A0 (en)	1999-10-28

Family

ID=8096378

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12736697A IL127366A0 (en)	1996-06-20	1997-06-19	Insulin preparations containing NaCl
IL127366A IL127366A (en)	1996-06-20	1998-12-02	Insulin preparations containing halogenide

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL127366A IL127366A (en)	1996-06-20	1998-12-02	Insulin preparations containing halogenide

Country Status (21)

Country	Link
EP (1)	EP0921812B2 (pt)
JP (2)	JP4404380B2 (pt)
KR (1)	KR100451778B1 (pt)
CN (1)	CN1120019C (pt)
AT (1)	ATE208208T1 (pt)
AU (1)	AU720484B2 (pt)
BR (1)	BR9709845B1 (pt)
CA (1)	CA2258097C (pt)
CZ (1)	CZ297937B6 (pt)
DE (1)	DE69708121T3 (pt)
DK (1)	DK0921812T4 (pt)
ES (1)	ES2167751T5 (pt)
HU (1)	HU228094B1 (pt)
IL (2)	IL127366A0 (pt)
NO (1)	NO324430B1 (pt)
PL (1)	PL189964B1 (pt)
PT (1)	PT921812E (pt)
RU (1)	RU2182015C2 (pt)
UA (1)	UA49890C2 (pt)
WO (1)	WO1997048414A1 (pt)
ZA (1)	ZA975470B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999034821A1 (en)	1998-01-09	1999-07-15	Novo Nordisk A/S	Stabilised insulin compositions
US6489292B1 (en)	1998-11-18	2002-12-03	Novo Nordisk A/S	Stable aqueous insulin preparations without phenol and cresol
EP1131089B1 (en) *	1998-11-18	2004-02-18	Novo Nordisk A/S	Stable aqueous insulin preparations without phenol and cresol
ATE220917T1 (de) *	1999-01-26	2002-08-15	Lilly Co Eli	Monodisperse formulierungen, die hexamere acylierte insulinanaloge enthalten
AU4937699A (en) *	1999-04-05	2000-10-23	Olga Evgenievna Kolesova	Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing
US7022674B2 (en)	1999-12-16	2006-04-04	Eli Lilly And Company	Polypeptide compositions with improved stability
EP1523993A1 (en) *	1999-12-16	2005-04-20	Eli Lilly & Company	Polypeptide compositions with improved stability
PL355378A1 (en) *	1999-12-16	2004-04-19	Eli Lilly And Company	Polypeptide compositions with improved stability
EP3689366A1 (en)	2004-10-05	2020-08-05	Novo Nordisk A/S	A pharmaceutical formulation
KR101820024B1 (ko)	2008-10-17	2018-01-18	사노피-아벤티스 도이칠란트 게엠베하	인슐린과 ｇｌｐ－1 효능제의 병용물
PL3417871T3 (pl)	2009-11-13	2021-06-14	Sanofi-Aventis Deutschland Gmbh	Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
LT2498801T (lt)	2009-11-13	2018-05-10	Sanofi-Aventis Deutschland Gmbh	Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
MX339614B (es)	2010-08-30	2016-06-02	Sanofi - Aventis Deutschland GmbH	Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl)	2011-08-29	2015-12-31	Sanofi Aventis Deutschland	Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
AU2013368990B2 (en) *	2012-12-26	2017-05-18	Wockhardt Limited	Pharmaceutical composition
TWI641381B (zh)	2013-02-04	2018-11-21	法商賽諾菲公司	胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
CN105960249B (zh)	2014-01-09	2021-03-16	赛诺菲	胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
CA2932873A1 (en)	2014-01-09	2015-07-16	Sanofi	Stabilized pharmaceutical formulations of insulin aspart
JP2020143105A (ja) *	2014-01-09	2020-09-10	サノフイＳａｎｏｆｉ	インスリンアスパルトの安定化された医薬製剤
JP2020114861A (ja) *	2014-01-09	2020-07-30	サノフイＳａｎｏｆｉ	インスリンアナログおよび／またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
BR112016013832A2 (pt)	2014-01-09	2017-08-08	Sanofi Sa	Uso de análogo e/ou derivado de insulina, formulação farmacêutica e processo para a preparação da mesma, kit e dispositivo médico
CA2970200A1 (en)	2014-12-12	2016-06-16	Sanofi-Aventis Deutschland Gmbh	Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK116527B (da) *	1967-03-01	1970-01-19	Nordisk Insulinlab	Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
US4783441A (en) †	1979-04-30	1988-11-08	Hoechst Aktiengesellschaft	Aqueous protein solutions stable to denaturation
US4439181A (en) *	1981-01-26	1984-03-27	Regents Of The University Of Minnesota	Polyol-hormone mixture for use in chronic parenteral hormone administration
AU550068B2 (en) †	1981-03-10	1986-02-27	Novo Nordisk A/S	Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) *	1984-05-29	1989-06-13	Eli Lilly And Company	Stabilized insulin formulations
PH25772A (en) *	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
PT93057B (pt) *	1989-02-09	1995-12-29	Lilly Co Eli	Processo para a preparacao de analogos da insulina
DE69416409T2 (de) *	1993-06-21	1999-09-16	Novo Nordisk A/S, Bagsvaerd	Asp-b28-insulinkristalle
JP3014764B2 (ja) *	1993-09-17	2000-02-28	ノボノルディスクアクティーゼルスカブ	アシル化インスリン
US5474978A (en) *	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations

1997
- 1997-06-19 EP EP97928123A patent/EP0921812B2/en not_active Expired - Lifetime
- 1997-06-19 UA UA98126686A patent/UA49890C2/uk unknown
- 1997-06-19 ES ES97928123T patent/ES2167751T5/es not_active Expired - Lifetime
- 1997-06-19 CA CA2258097A patent/CA2258097C/en not_active Expired - Lifetime
- 1997-06-19 PL PL97330763A patent/PL189964B1/pl unknown
- 1997-06-19 DE DE69708121T patent/DE69708121T3/de not_active Expired - Lifetime
- 1997-06-19 CZ CZ0395698A patent/CZ297937B6/cs not_active IP Right Cessation
- 1997-06-19 BR BRPI9709845-0A patent/BR9709845B1/pt not_active IP Right Cessation
- 1997-06-19 HU HU9904031A patent/HU228094B1/hu unknown
- 1997-06-19 CN CN97195648A patent/CN1120019C/zh not_active Expired - Lifetime
- 1997-06-19 DK DK97928123.5T patent/DK0921812T4/da active
- 1997-06-19 PT PT97928123T patent/PT921812E/pt unknown
- 1997-06-19 KR KR10-1998-0710429A patent/KR100451778B1/ko not_active IP Right Cessation
- 1997-06-19 AT AT97928123T patent/ATE208208T1/de active
- 1997-06-19 JP JP50212998A patent/JP4404380B2/ja not_active Expired - Lifetime
- 1997-06-19 RU RU99101068/14A patent/RU2182015C2/ru active
- 1997-06-19 WO PCT/DK1997/000268 patent/WO1997048414A1/en active IP Right Grant
- 1997-06-19 IL IL12736697A patent/IL127366A0/xx active IP Right Grant
- 1997-06-19 AU AU32536/97A patent/AU720484B2/en not_active Expired
- 1997-06-20 ZA ZA9705470A patent/ZA975470B/xx unknown
1998
- 1998-12-02 IL IL127366A patent/IL127366A/en not_active IP Right Cessation
- 1998-12-18 NO NO19985981A patent/NO324430B1/no not_active IP Right Cessation
2009
- 2009-05-07 JP JP2009112970A patent/JP2009235075A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU3253697A (en)	1998-01-07
ES2167751T3 (es)	2002-05-16
CA2258097A1 (en)	1997-12-24
NO324430B1 (no)	2007-10-15
EP0921812B1 (en)	2001-11-07
CA2258097C (en)	2011-02-08
ATE208208T1 (de)	2001-11-15
UA49890C2 (uk)	2002-10-15
JP2009235075A (ja)	2009-10-15
KR100451778B1 (ko)	2004-11-16
WO1997048414A1 (en)	1997-12-24
ZA975470B (en)	1997-12-22
DK0921812T4 (da)	2012-04-02
DE69708121T3 (de)	2012-05-16
CN1120019C (zh)	2003-09-03
ES2167751T5 (es)	2012-03-30
JP2000513344A (ja)	2000-10-10
DK0921812T3 (da)	2002-02-11
EP0921812B2 (en)	2011-12-21
HUP9904031A3 (en)	2000-10-30
CZ297937B6 (cs)	2007-05-02
HU228094B1 (en)	2012-10-29
JP4404380B2 (ja)	2010-01-27
HUP9904031A2 (hu)	2000-04-28
PL189964B1 (pl)	2005-10-31
DE69708121D1 (de)	2001-12-13
CZ395698A3 (cs)	1999-05-12
KR20000022031A (ko)	2000-04-25
BR9709845A (pt)	1999-08-10
IL127366A (en)	2007-07-04
AU720484B2 (en)	2000-06-01
PL330763A1 (en)	1999-05-24
PT921812E (pt)	2002-04-29
EP0921812A1 (en)	1999-06-16
NO985981D0 (no)	1998-12-18
CN1222083A (zh)	1999-07-07
NO985981L (no)	1998-12-18
DE69708121T2 (de)	2002-08-01
BR9709845B1 (pt)	2008-11-18
RU2182015C2 (ru)	2002-05-10

Publication	Publication Date	Title
IL127366A0 (en)	1999-10-28	Insulin preparations containing NaCl
AU635358B2 (en)	1993-03-18	Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DE69737995D1 (de)	2007-09-20	INSULINPREPARATION MIT MAnnitol
CA2075060A1 (en)	1991-08-04	Novel vehicle gases and their use in medical preparations
PL347210A1 (en)	2002-03-25	Stable concentrated insulin preparations for pulmonary delivery
DE69417252D1 (de)	1999-04-22	Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
EP0950665A4 (en)	2004-05-06	PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
ES2162951T3 (es)	2002-01-16	Estabilizacion de composiciones de prostaglandina.
EP0573423A4 (en)	1994-06-01	Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
ATE204297T1 (de)	2001-09-15	Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
NO20012249D0 (no)	2001-05-07	Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat
ATE92542T1 (de)	1993-08-15	Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor\|than.
AU631334B2 (en)	1992-11-19	2-substituted n,n'-ditrimethoxybenzoyl piperazines, and therapeutic compositions containing them
ES2152315T3 (es)	2001-02-01	Xamoneline tartrato.
ATE196914T1 (de)	2000-10-15	Lh-rh analoge mit starrer konformation, deren verwendungen und pharmazeutische zusammensetzungen
DK0626173T3 (da)	1997-05-12	Aerosolpræparat indeholdende fusafungin
DE59101818D1 (de)	1994-07-14	Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
FR2707492B1 (fr)	1995-08-25	Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
FR2696926B1 (fr)	1994-12-09	Prothèse totale du genou du type intracondylienne.
ATE204286T1 (de)	2001-09-15	Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
DE58902178D1 (en)	1992-10-08	Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
Greer	1989	Effects of NaCl on tobacco callus cultures
ATE101194T1 (de)	1994-02-15	Azeotropaehnliche zusammensetzungen von 1,3dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
ATE70840T1 (de)	1992-01-15	Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
ATE82855T1 (de)	1992-12-15	2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Legal Events

Date	Code	Title	Description
2007-12-03	FF	Patent granted
2008-01-06	KB	Patent renewed